For general information only. Not a substitute for professional medical advice.
Medi Info Hub Logo
Educational Medication GuidePrescriptionClass: Antidiabetic (SGLT2 Inhibitor)

Jardiance

Generic Name: Empagliflozin

Common Brand Names: Jardiance
Dosage Form:Oral Tablets
Route:Oral
Pregnancy Category:Category C
Last Reviewed:9/21/2026

Uses & Medical Indications

Improve glycemic control in type 2 diabetes; reduce risk of cardiovascular death and hospitalization in adults with heart failure.

Medical Conditions Treated:

Type 2 Diabetes, Heart Failure, Chronic Kidney Disease

Work Mechanism & Pharmacology

How It Works

Patient Overview of Work Mechanism

Jardiance works in the kidneys to filter out excess blood sugar directly into the urine, protecting both the heart and kidneys while lowering blood sugar levels.

Clinical Mechanism of Action (MoA)

Potent, competitive, selective sodium-glucose cotransporter 2 (SGLT2) inhibitor in the proximal renal tubules. Promotes urinary excretion of excess glucose and sodium, reducing plasma glucose levels, systemic blood pressure, glomerular hyperfiltration, and cardiac preload/afterload.

Primary TargetEmpagliflozin
Therapeutic FamilyAntidiabetic / Cardiorenal Protective
Administration RouteOral

Dosage & Administration Guidelines

Adult Dosage

10 mg orally once daily in the morning; may increase to 25 mg once daily.

Pediatric Dosage

Safety not established in pediatric patients.

Elderly / Geriatric Considerations

No specific adjustment, but monitor for volume depletion.

Maximum Dose Limit

25 mg daily.

Renal Impairment:

Contraindicated on dialysis; dose adjustment not needed if eGFR >= 20 mL/min for heart failure/CKD indications.

Hepatic Impairment:

No adjustment in mild/moderate hepatic impairment.

Side Effects & Safety Warnings

Common Side Effects

Urinary tract infections, mycotic genital infections, increased urination.

Serious Adverse Reactions

Ketoacidosis, urosepsis, necrotizing fasciitis of perineum (Fournier gangrene), hypotension.

Contraindications:

Severe hypersensitivity to empagliflozin, patients on dialysis.

Important Warnings & Precautions:

Assess for ketoacidosis in symptomatic patients; temporary discontinuation before surgery.

Interactions (Drugs, Food & Alcohol)

Drug-Drug Interactions:

Diuretics (increased risk of hypotension), insulin secretagogues.

Food & Dietary Interactions:

Can be taken with or without food.

Alcohol Interaction Warning:

Heavy drinking increases ketoacidosis risk.

Pregnancy & Breastfeeding Safety

Pregnancy Safety

Not recommended during second and third trimesters.

Breastfeeding / Lactation

Not recommended due to potential for serious adverse reactions in infant kidney development.

Patient Counseling & Practical Advice

How to Take:

Stay well-hydrated throughout the day and practice good personal hygiene.

What to Do if You Miss a Dose:

Take it when remembered, but never take two doses on the same day.

Recommended Monitoring & Lab Tests:

Blood pressure, renal function, signs of genital/urinary infection.

Related Medicines in Antidiabetic (SGLT2 Inhibitor)

Emergency Medical Warning

When to Seek Urgent Medical Attention

Seek immediate emergency medical care (call emergency services or proceed to the nearest emergency department) if you experience signs of a life-threatening allergic reaction (anaphylaxis: facial, lip, tongue, or throat swelling causing airway obstruction), severe cutaneous blistering with skin peeling, sudden intense chest pain, or symptoms of overdose.

Emergency Safety Protocol: If an intentional or accidental overdose is suspected, contact your regional Poison Control Center or emergency services immediately. Do not induce vomiting unless strictly advised by emergency healthcare personnel.
Educational Sources & References

Content for Jardiance was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:

  • Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
  • World Health Organization (WHO) — Model List of Essential Medicines
  • Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
  • National Health Service (NHS) — Medicines A to Z Clinical Guidelines
Published by: Medi Info Hub TeamLast Updated: 10/19/2026

The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.